By ThinkSabio #ThinkSabio US Market Morning Brief
Pre-Market Gainers
$NRXS + 150%: NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms
$SYTA + 52%
$EYEN + 43%: Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results (May 19)
Pre-Market Decliners:
$HKPD – 13%
$YALA – 13%: Yalla Group Ltd (YALA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth
Pre-Market Penny Gainers:
$BLMZ + 120%
$AXDX + 66%
$PRPH + 15%: ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
Headlines
$PFE Pfizer licenses 3SBio cancer drug for $1.25B upfront
$GOOG #GOOGL Alphabet’s Waymo cleared to expand robotaxi service in Bay Area